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Abstract
When effective medical treatment and vaccination are not available,
non-pharmaceutical interventions such as social distancing, home quarantine and
far-reaching shutdown of public life are the only available strategies to prevent the
spread of epidemics. Based on an extended SEIR
(susceptible-exposed-infectious-recovered) model and continuous-time optimal
control theory, we compute the optimal non-pharmaceutical intervention strategy
for the case that a vaccine is never found and complete containment (eradication of
the epidemic) is impossible. In this case, the optimal control must meet competing
requirements: First, the minimization of disease-related deaths, and, second, the
establishment of a sufficient degree of natural immunity at the end of the measures,
in order to exclude a second wave. Moreover, the socio-economic costs of the
intervention shall be kept at a minimum. The numerically computed optimal control
strategy is a single-intervention scenario that goes beyond heuristically motivated
interventions and simple “flattening of the curve”. Careful analysis of the computed
control strategy reveals, however, that the obtained solution is in fact a tightrope walk
close to the stability boundary of the system, where socio-economic costs and the
risk of a new outbreak must be constantly balanced against one another. The model
system is calibrated to reproduce the initial exponential growth phase of the
COVID-19 pandemic in Germany.
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1 Introduction
Preventing the spread of new diseases, to which there is no immunity in the population,
is a huge problem, since there are often neither vaccines nor other effective medical treat-
ments available in the early stages. In this case, non-pharmaceutical interventions (NPIs)
such as intensive hand hygiene, home quarantine and measures of social distancing, e.g.
closure of schools, universities and shops, prohibition of mass events up to curfew and
shutdown of entire territories, are the only available measures. The NPIs are aimed at
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“flattening the curve”, i.e., a reduction of the transmission rate in order to break the expo-
nential growth of the epidemic.
In the case of the currently spreading COVID-19 pandemic caused by the new SARS-
CoV2 coronavirus [1, 2], the fundamental concern of the mitigation measures is not to ex-
ceed the available number of intensive care unit (ICU) beds, in particular for respiratory
support or extracorporeal membrane oxygenation, in order to prevent actually avoidable
deaths [3]. Since the outbreak of the epidemic, a large number of simulation studies have
been conducted using mathematical models to assess the efficacy of different NPIs and to
estimate the corresponding demands on the health care system [4–12]. Moreover, math-
ematical models are employed to deduce important epidemiological parameters [13–15]
and to evaluate the effect of particular measures from empirical data [16, 17].
The vast majority of research papers on the control of COVID-19 examines the im-
pact of rather simple intervention schemes such as bang-bang control or cascaded on-off
(i.e., repeated lockdown and release) strategies [12, 18–20]. Instead, however, intervention
strategies derived from continuous-time optimal control theory [21] following a varia-
tional principle are actually preferable. There is a large number of studies on the applica-
tion of optimal control theory following Pontryagin’s maximum principle [22] in math-
ematical epidemiology, see Refs. [23–27] and references therein. The by far largest part
of these works deals with optimal control of epidemics through vaccination and immu-
nization [28–31], medical treatment [32, 33] and combinations thereof [34–39]. Signifi-
cantly fewer papers are concerned with the optimal control of transmission dynamics and
the mitigation of epidemics through social distancing measures. The paper by Behncke
[25] studies the optimal control of transmission dynamics via optimally steered health-
promotion campaigns and seems to be one of the first works devoted to this problem.
During the current COVID-19 pandemic, the control of the disease by NPIs has moved
into the focus of attention and a number of recent papers are devoted to this problem.
Djidjou-Demasse et al. [40] investigated the optimal control of the epidemic via social
distancing and lockdown measures until a vaccine becomes available. They propose to
delay the peak of the epidemic by increasingly strict interventions and finally to relax the
measures in such a way that a significant burden on the health care system only occurs
when the availability of a vaccine is already expected. A similar problem has been consid-
ered by Perkins and España [41], who studied the optimal implementation of NPIs under
the assumption that an effective vaccine would become available in about one year after
the outbreak of the epidemic. The paper by Kruse and Strack [42] is devoted to the analysis
of the optimal timing of social distancing measures under the constraint that the overall
(temporal) budget for NPIs is limited. Ketcheson [43] presented a detailed analysis for
optimal transmission control in a SIR (susceptible-infected-recovered) epidemic model
with the aim of achieving a stable equilibrium (“herd immunity”) within a fixed finite time
interval while simultaneously avoiding hospital overflow. A similar problem (including a
simple state-dependent mortality rate) was studied by Alvarez et al. [44], who focussed
on minimizing the lockdown costs and included further economic aspects such as the as-
sumed value of statistical life. An extension of the optimal transmission control problem
to an age-structured model has been presented by Bonnans and Gianatti [45], who pro-
posed a different temporal course of the contact reduction for the high and low risk sub-
populations. Köhler et al. [46] have applied model predictive control to social distancing
measures with the objective of minimizing the fatalities over a fixed period of time of two
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years. Next to adaptive feedback strategies for iterative loosening of the social distancing
policies after an initial lockdown, the authors also examined the possibility of eradicating
the virus. All of these papers on optimal control deal with deterministic epidemiological
models, in particular the basic SIR model [25, 42–44, 47] or various extended SEIR-type
models [40, 41, 46]. We remark that this survey on optimal control of COVID-19 is not
exhaustive.
The objective of this paper is the investigation of the optimal control of epidemics in the
(hopefully unlikely) case in which an effective vaccine is impossible or never found and the
epidemic must be controlled with purely non-pharmaceutical measures. Furthermore, we
exclude the possibility of complete containment (“eradication of the virus”). Then, opti-
mal control must pursue competing objectives: On the one hand, the number of disease-
related deaths shall be minimized by strictly avoiding an overload of the intensive care
treatment capacities. On the other hand, however, sufficient natural immunity must be
established in the population in the long run to prevent a second outbreak of the epi-
demic (“herd immunity”). Moreover, the socio-economic costs of the intervention shall
be kept at a minimum. We compute the optimal solution to this problem by applying Pon-
tryagin’s Maximum Principle to an extended SEIR-type model tailored to specific aspects
of COVID-19. Our main result is the optimal time course of the mean contact reduction
(and the corresponding time-dependent effective reproduction number) that serves as a
guideline on how to optimally enter and finally exit the lockdown. The corresponding NPI
policy is a single-intervention scenario that can be divided into three distinct phases: (1) a
strict initial lockdown, (2) a long lasting period (“critical period”) during which the num-
ber of active cases is kept approximately constant and (3) a moderate tightening of the
measures towards the end of the intervention. We present a detailed analysis of the nu-
merically computed result and develop an analytical understanding of its distinct features.
Moreover, we show that our numerically computed optimal control obeys two fundamen-
tal stability criteria, which impose an upper limit on the transmission rate and its rate of
change on the way out of the initial lockdown. The precise structure of the optimal control
(i.e., three phases of the intervention) obtained in this paper differs from the results de-
scribed in similar works [42–44]. After the initial submission of this paper, the preprint by
Charpentier et al. [48] appeared, who studied a similar optimization problem on the basis
of an extended SIR-type model with parameters adjusted to the COVID-19 pandemic in
France. Their independently obtained results are comparable to those presented in this
paper, which demonstrates the robustness of the obtained optimal intervention strategy
with respect to model and parameter variations.
The mathematical model for the progression of the epidemic and the estimation of the
demand for intensive care resources is described in Sect. 2. The optimal control prob-
lem is derived in Sect. 3 and the results are described in Sect. 4. We close with a critical
discussion of our findings in Sect. 5. The model has been calibrated to reproduce the expo-
nential growth phase of the COVID-19 pandemic in Germany. Details on the parameter
adjustment are described in the Appendix.
2 Modeling of disease spreading and demand for intensive care units
Mathematical modeling of the spread of epidemics is an indispensable tool to project the
outcome of an epidemic, estimate important epidemiological parameters and to make
predictions for different intervention scenarios. Compartment models [49–51], where
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the population is divided into different macroscopic sub-populations, such as suscepti-
ble, infectious, recovered etc., are a simple but effective tool to model the progression
of epidemics. In contrast to complex (but more realistic) stochastic agent-based mod-
els [52, 53], deterministic mean-field models are limited to the description of the average
infection dynamics in macroscopic (sub-)populations, but allow for fast parameter scans
and a straightforward application of continuous-time optimal control theory [21].
2.1 Model equations
In this paper, an extended SEIR model, similar to that proposed by Neher et al. [54, 55], is
used to model the spread of an epidemic and to estimate the number of patients in a critical
state that require intensive care. Similar models are described in Refs. [14, 46, 56]. For the
sake of simplicity, vital dynamics (except for disease-related deaths), seasonality effects
[57], dispersion of transmission [58] and any effects caused by population heterogeneity
(different age and risk groups) are neglected. The total population is divided into distinct
compartments: susceptible S, exposed E, infectious I , hospitalized H (severely ill), critical









İ = γlE – γiI, (1c)
Ḣ = (1 – m)γiI +
(
1 – f (C/C0)
)
γcC – γhH , (1d)
Ċ = cγhH – γcC, (1e)
Ṙ = mγiI + (1 – c)γhH , (1f)
Ḋ = f (C/C0)γcC. (1g)
The group of initially healthy and not yet infected (susceptible, S) is vulnerable to infection
through contact with infectious (I), who may transmit the disease to the susceptible popu-
lation. The infection probability is determined by the transmission rate β , and the share of
the susceptible and infectious population on the total (living) population N = N(t), which
is given as
N = S + E + I + H + C + R. (2)
The newly infected (exposed, E) become infectious themselves only after a latency period
γ –1l (which must not be confused with the incubation time). The infectious either recover
or turn severely ill after an average period γ –1i . Severely ill (H) can either deteriorate into a
critical state (C) or recover after a period γ –1h . The recovered population (R) is assumed to
be immune against new infections. Patients in a critical state either stabilize to the severely
ill state or die from the disease on a time scale γ –1c . The disease-related deaths reduce the
size of the population
Ṅ = –Ḋ, (3)
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Figure 1 (a) Schematic illustration of the compartmental epidemic model (1a)–(1g). The function u(t)
describes a modification of the transmission dynamics due to NPIs. (b) State-dependent mortality rate f as a
function of the number of patients in a critical state requiring intensive care. The mortality rate grows rapidly if
the number of critical patients exceeds the number of available ICUs C0. Inset: The solid line is the regularized
mortality rate (4b) that is used in the computations throughout the paper
such that, assuming initially D(0) = 0, it holds N(t) = N(0) – D(t). Moreover, m is the share
of infectious that are asymptomatic or have at most mild symptoms, c is the fraction of
severely ill that become critical and f is the fraction of critically ill that are going to die
from the disease. Finally, the time-dependent function u(t) describes a modification of the
transmission rate (mean contact reduction) due to NPIs. Here, u = 1 means no interven-
tion, and u = 0 corresponds to the extreme case of total isolation of the whole population.
The model system is illustrated in Fig. 1(a). A rescaled version of the dynamical system
(1a)–(1g), where the sub-populations are considered in terms of their relative share of the
initial population N(0), is given in Eq. (23a)–(23g) in the Appendix D.
2.2 State-dependent fatality rate
The disease-related mortality grows tremendously as soon as the number of critically ill
exceeds the capacity limit C0 of the health care system (number of available ICUs). This










f0 for C ≤ C0,
f1 – C0C (f1 – f0) for C > C0.
(4a)
As long as every critical patient can be served with an ICU (C ≤ C0), the fatality rate is
a constant f = f0. As soon as the ICU resources are exceeded, an increasing fraction of
the critical patients dies with a higher rate f1 > f0, which on average results in the state-
dependent fatality rate (4a). Here, f1 = 2f0 is assumed. In the following, the regularization







(f1 – f0) (4b)
with 0 < ε  1, of Eq. (4a) is used, in order to avoid problems due to the non-
differentiability at C = C0. The function f (C/C0) is plotted in Fig. 1(b).
2.3 Basic and effective reproduction number
The basic reproduction number [59]
R0 = β/γi (5)
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Figure 2 (a) Evolution of the epidemic without interventions (u = 1). The number of available ICUs was set to
C0 = 30,000. The inset shows the overflow in ICU demand, which leads during a period of about 57 days to an
increased mortality rate according to Eq. (4a)–(4b). (b) Same as in (a) but on a logarithmic scale. The markers
indicate the estimated number of cumulative cases (see Appendix C) and the reported numbers for ICU
demand and deaths during the early phase of the COVID-19 pandemic in Germany. The first disease-related
fatalities were reported on March 9, 2020 (day number 20 in the simulation). Social distancing measures,
which came into force nationwide in mid-March [16], have flattened the initial exponential growth
can be thought of as the expected number of cases (without intervention, u = 1) that is
directly generated by one case in a population where all individuals are susceptible to in-
fection. The effective reproduction number
Reff(t) = R0u(t)S(t)/N(t) (6)
depends on time and includes the impact of intervention measures.
2.4 Numerical results for the uncontrolled epidemic (COVID-19 in Germany)
Figure 2 shows the progression of an uncontrolled epidemic starting from an initially small
fraction of exposed population. The initial conditions are listed in Appendix D. The pa-
rameters are adjusted (see Appendix C) to reproduce the initial exponential growth phase
of the COVID-19 disease in Germany (late February – mid March 2020) and are summa-
rized in Table 1. The numerical solution was obtained by a 4th order Runge–Kutta method.
Without intervention, the peak number of simultaneously active cases is about 23 million
and the peak number of patients in a critical state exceeds the number of ICUs by a factor
of about Cmax/C0 ≈ 16.7, see inset of Fig. 2(a). The simulated value Cmax ≈ 5.0 × 105 is
in very good agreement with the projection by Khailaie et al. [14]. Due to the increased
fatality in the period with ICU overflow, see Eq. (4a)–(4b), the epidemic terminates with a
very high number of deaths D(T) ≈ 1.0 × 106, which is in line with previous studies [11].
3 Optimal control
In the scenario outlined in Sect. 1, where an effective vaccine is never found, the optimal
transmission control due to NPIs is required (i) to avoid ICU overflow (more patients in
a critical state than available ICUs) but at the same time (ii) exclude a second wave of the
epidemic after the end of the measures. The optimal solution is computed by minimizing
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Table 1 List of parameters used in the simulations. See Appendix C for details
Symbol Value Description
R0 2.7 basic reproduction number
N(0) 83× 106 initial population size
γ –1l 2.6d average latency time between exposure and infectious period
γ –1i 2.35d average infectious period before recovery or hospitalization
γ –1h 4.0d average period before severely ill patients turn critical or recover
γ –1c 7.5d average period before critical patients recover or die
β (1.15d)–1 transmission rate
m 0.92 fraction of infected with at most mild symptoms
c 0.27 fraction of hospitalized patients that turn critical
f see Eq. (4a)–(4b) fraction of critical patients that turn fatal
f0 0.31 mortality of a critical patient with ICU
f1 2 f0 = 0.62 mortality of a critical patient without ICU
C0 variable number of ICUs/ max. number of simultaneously critical cases
T 10× Tcrit final time of the simulation, for Tcrit see Eq. (17)
the index functional



























is the terminal cost function. The first term in Eq. (7b) describes the number of disease-
related deaths D(T) at the end of the epidemic, which should be minimized. As the in-
crement of the disease-related deaths depends on the state-dependent fatality rate, see
Eq. (1g), this condition implies that the ICU capacities must not be exceeded. The second
term in Eq. (7b) controls the size of the of susceptible population S(T) at the end of the
epidemic. In order to approach a stable, disease-free stationary state (“herd immunity”),
the share of susceptibles on the total population must be less than R–10 at the end of the
intervention, see Appendix A. The term in Eq. (7b) enforces a final state slightly below the
stability boundary (just in the stable regime), where 0 < ε  1 is a small parameter. We
use ε = 10–2 in the numerical simulations throughout this paper. The function
C(x) = x log (x) – x + 1 (8)
is convex on the whole domain x ∈ [0,∞). It appears also in the last term of Eq. (7a) as
an intermediate cost function, which provides an abstract measure for the total socio-
economic costs caused by the intervention. The term is minimal and zero if no interven-
tion is applied C(1) = C ′(1) = 0, see Fig. 3. The advantage of using (8) over the commonly
used quadratic cost functions is that “unphysical” negative values of u are a priori excluded.
The control parameter P balances between the competing objectives of minimal disease-
related deaths (first term), while attaining at the same time a minimum number of cases to
enforce S(T) slightly below the stability boundary (second term). Ramping up P puts an
increasing emphasis on minimizing the disease-related deaths. The time interval [0, T] of
the simulation is chosen sufficiently large, such that the results are practically independent
from the chosen final time T , see Table 1.
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Figure 3 Plot of the cost functions for (a) minimal intermediate costs and (b) the enforcement of herd
immunity at the end of the intervention for different values of ε. We use the short notation X =R0S(T )/N(T ).
The shaded region corresponds to unstable terminal states
From the augmented index functional [21]













+ λ(t) · (F(x(t), u(t)) – ẋ(t))),
where x = (S, E, I, H , C, R, D) is the state vector, ẋ = F(x, u) is the dynamical system (1a)–
(1g) and λ(t) is a vector of time-dependent Lagrange multipliers (also denoted as co-state
variables) λ = (λS,λE ,λI ,λH ,λC ,λR,λD), one obtains the Hamiltonian function
H(x, u,λ) = C(u) + λ · F(x, u). (9)
Following Pontryagin’s maximum principle [21, 22], the optimality condition reads
∂H
∂u







Finally, the co-state equations and the final time conditions are obtained as
λ̇(t) = –∇xH, (11)
λ(T) = ∇x ϕ(x)|T . (12)
Together with the initial conditions x(0), the system (1a)–(1g), (11)–(12) represents a non-
linear two-point boundary value problem. The full set of equations is given in Appendix D.
Numerical solutions are obtained by using Matlab’s built-in routine bvp4c [60] in combi-
nation with an analytic Jacobian matrix and a step-size adaptive homotopy method, where
the control parameter P is gradually ramped up while always using the result of the pre-
vious step as initialization. The procedure is initiated from the numerical solution of the
initial value problem (1a)–(1g) without interventions, see Fig. 2.
4 Results
4.1 Structure of the optimal intervention strategy
With optimal control of the transmission rate (in the sense of Sect. 3) via accordingly
steered NPIs, the epidemic develops dramatically different from the uncontrolled case.
The whole intervention is shown in Fig. 4 and can be structured into three phases:
Kantner and Koprucki Journal of Mathematics in Industry           (2020) 10:23 Page 9 of 23
Figure 4 Optimal transmission control for C0 = 30,000 available ICUs. (a) Temporal evolution of the optimally
controlled epidemic. The susceptible population terminates slightly below the critical valueR–10 , which
guarantees herd immunity and rules out a second wave of the epidemic. Moreover, the optimal control
ensures that the available number of ICUs is not exceeded by the critically ill: C(t) < C0 for all t ∈ [0,∞). A more
detailed plot of the ICU load is given in Fig. 5(c). (b) Effective reproduction number (6) corresponding to the
optimally steered intervention. The optimal mean contact reduction u(t) is shown for comparison.
(c) Comparison of the trajectories of the uncontrolled (dashed lines) and the optimally controlled epidemic
(solid lines) in different projections of the state space. The arrows indicate the direction of time. The grey
shaded region highlights the critical period
1. The intervention begins with a strict initial “lockdown” that is built up over a period
of about 25 days (starting around day 25), see Fig. 4(a), (b). The effective
reproduction number (6) must be held below one Reff < 1 for about 13 days, see
Fig. 4(b) and Fig. 5(b). This strict initial intervention breaks the early exponential
growth and damps the peak number of infected such that an overshoot of the
critically ill population beyond C0 is just barely avoided, see Fig. 4(a) and Fig. 5(c).
2. The initial lockdown is followed by a long period (about 300 days in the case of
C0 = 30,000), which is denoted as the “critical period” in the following, during which
the number of simultaneously active cases is kept approximately constant. This
corresponds to an effective reproduction number Reff ≈ 1, see Fig. 4(b). During this
phase, the intensive care system is constantly stressed by slightly less than C0 patients
in a critical state. This situation must of course be avoided in reality by all means, in
particular, since stochastic fluctuations of the case number are not included in the
deterministic model (1a)–(1g) at all. During this period, the NPIs are relaxed on a
gradually increasing rate, but initially (when the disease is not yet widespread in the
population) only very slowly, see Fig. 4(b). The duration of the critical period scales
with C–10 . Further details are discussed in Sect. 4.3 below.
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Figure 5 (a) Optimal time evolution of the transmission control function u(t) for different values of C0. The
value of C0 is color-coded. In all scenarios, the interventions start with a strict lockdown, where u(t) is reduced
belowR–10 for about 10 to 12 days. This initial lockdown is followed by a long “critical period” during which
the measures are gradually relaxed. The length of this period is determined by the peak number of
simultaneously critically infected C0. Towards the end of the intervention, a moderate tightening of the NPIs is
required. (b) Same as (a), but zoomed on the region with u(t) <R–10 . (c) By optimal transmission control, the
number of patients in a critical state C is kept below the limiting value C0 at all times. (d) Characteristic time
span TFWHM of the critical period during which the peak number of simultaneously infected must be held
constant. The dashed line shows the analytical approximation Tcrit given in Eq. (17). (e) Total number of
disease-related deaths (solid lines) and total costs of the measures (dashed lines) at the end of the epidemic
vs. the control parameter P (see Sect. 3). The optimized transmission function minimizes the number of
disease-related deaths to a C0-independent value for P → ∞, but to a high cost in the case of low C0. The
squares indicate the minimal values of P that guarantee C(t) < C0 for all times
3. After the critical period, i.e., when the number of active cases starts to decay, a final
moderate tightening of the measures is required. This is reflected by a notable dip in
the transmission control function and a reduction of the effective reproduction
number below one, see Fig. 4(b). This final intervention reflects the requirement to
meet the herd immunity threshold towards the end of the intervention. An
unnecessarily wide overshooting into the stable regime would result in additional
infections and deaths, see Sect. 4.4. Finally, the measures are lifted on a gradually
decreasing rate while the system slowly approaches the herd immunity threshold.
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Figure 4(c) shows the trajectories of the controlled and the uncontrolled epidemic in dif-
ferent state space projections. By controlling the transmission of infection, the enormous
excursion of the trajectory is prevented and the optimal path to a stable disease-free sta-
tionary state is taken. Note that the uncontrolled epidemic terminates far in the stable
regime (S(T)/N(T) R–10 ), whereas in the optimally controlled case the final state is just
slightly below the stability threshold S(T)/N(T) R–10 .
We point out that the optimal transmission control described above differs from the re-
sults obtained for similar optimization problems considered in Refs. [43, 44, 47], which
do not exhibit the distinct structural features of the intervention (initial lockdown, criti-
cal period, final phase intervention) presented here. A comparable result was described in
Ref. [48], where the intervention was divided into four different phases which essentially
coincide with our findings. Merely the lockdown was further subdivided into a “quick ac-
tivation of a strong lockdown” and a “light lockdown release.”
4.2 Dependence on the maximum number of simultaneously critical cases
The state-dependent mortality rate (4a)–(4b) effectively imposes a state-constraint that
strictly enforces C < C0 for P → ∞, i.e., a maximum number of simultaneously infected
in a critical condition. In principle, this allows to investigate the optimal control of other
(less extreme) scenarios, where the maximum number of simultaneously critically infected
should be held far below the number of available ICUs (i.e., the meaning of C0 will be
reinterpreted). In this case, the increased mortality rate f1 is an artificial parameter that
penalizes the excess of the critically infected population over a freely chosen threshold
of C0. By ramping up the control parameter P , an optimal solution with C(t) < C0 for all
t ∈ [0,∞) is found, that is independent of f1.
Figure 5 shows the optimal control for different values of C0. The time course of the op-
timally controlled transmission rate is qualitatively the same for all considered values of
C0, see Fig. 5(a), (b). Most notably, the time scale of the entire intervention scenario is gov-
erned by the duration of the critical period, during which the number of critical patients is
held at C  C0, see Fig. 5(c). We characterize this time scale by the full width half maximum
(FWHM) time TFWHM = t2 – t1, where t1 and t2 > t1 are the two points in time at which the
number of critically infected equals half the allowed maximum value: C(t1) = C(t2) = C0/2.
As shown in Fig. 5(d), the FWHM time scales inversely with the peak number of simulta-
neously infected in a critical state: TFWHM ∼ C–10 . The minimization of the disease-related
deaths is controlled by the parameter P in the terminal cost function (7b). Figure 5(e)
displays the progression of the optimization routine into the targeted optimal state (i.e.,
without excess of C0) while P is ramped up. At a certain value of P , which depends on
C0, the routine reaches a plateau where both the number of disease-related deaths as well
as the total costs of the intervention measures
∫ T
0 dt C(u(t)) become constant. The corre-
sponding values ofP , which correspond to the scenario that fully avoids excess of critically
ill over C0, are located on that plateau and are marked by square symbols in Fig. 5(e). The
optimized transmission function minimizes the number of disease-related deaths to a C0-
independent value Dmin(T) for P → ∞, but at total cost that scales with C–10 . An analytical
estimate of the minimum attainable number of deaths is given in Eq. (18).
Within the present model, further reduction of disease-related deaths below Dmin(T)
can only be achieved by pharmaceutical interventions, in particular by vaccination. The
result of the C0-independent number of deaths at the end of the epidemic is an artifact
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of the simplified modeling framework, in which a homogeneous population with an aver-
aged set of parameters is considered. Since the mortality rate typically strongly depends
on age and health condition, it might be advisable to extend the model and divide the
compartments into several age or risk groups as in Refs. [11, 45, 54, 61]. The so-extended
model features a matrix-valued transmission rate, which describes the infections caused
by contacts within and between different groups, that could be further optimized by intra-
and intergroup-specific measures. This is, however, beyond the scope of this paper.
4.3 Analysis of the critical period
The numerical results shown in Fig. 4(a), (b) indicate that during the critical period the
populations S, R, and D change approximately linear, while the active cases (E, I , H , C) are
practically constant. To gain further insights, we consider the ansatz (for t > t∗)













where t∗ is a reference time that depends on the initial conditions, γS , γR, γD are initially
unknown rates and the infected sub-populations (E, I, H , C) ≈ (E∗, I∗, H∗, C0) are constant.
From substituting the ansatz into the model equations (1a)–(1g), one obtains by a straight-
forward calculation analytical expressions for the rates
γS =
1 – c(1 – f0)
(1 – m)c
γcC0, γR =
1 – c(1 – mf0)
(1 – m)c




γS, I∗ ≈ 1
γi





The rate of new infections per day γS during the critical period depends only on the pa-
rameters of the disease and the maximum capacity C0. Note that it holds γS = γR + γD,
i.e., the number of active cases remains constant since susceptibles become infected at the
same rate on which active cases either recover or die. The number of active cases in this
dynamical equilibrium is a multiple of C0:
N∗act = E
∗ + I∗ + H∗ + C∗ =
(

















With the parameters listed in Table 1, we find N∗act ≈ 28.3C0, i.e., one out of about thirty
infections turns critical.
Let us now come to the major results of this section. The ansatz stated above yields an
instantaneous relationship between the current value of the transmission control function



















for a certain range of t in t∗ < t < Tcrit with Tcrit defined below. Here, we approximated
N(t) ≈ N(0) (since γD  γS). Note that Eq. (13) implies Reff ≈ 1 during the critical period.
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Figure 6 (a) Analysis of the optimal mean contact reduction u(t) during the critical period, where the
number of simultaneously infected must be kept constant (the plot is for C0 = 10,000). The numerically exact
result is plotted along with the stability boundaryR–10 N(t)/S(t) (blue dashed line) and the analytical
approximation (13) (red dotted line). The inset shows that the optimal control respects the stability
requirement (14) during the critical period. (b) Plot of effective reproduction numberReff(t) corresponding to
the optimal control. Throughout the critical period,Reff(t) is kept slightly below one
This approximate relation is an interesting result, as it hints that the obtained optimal
control steers the system’s trajectory close to the stability boundary. Comparison with the
stability criterion for the disease-free stationary state R0 < N̄/S̄, see Eq. (19), suggests that







This allows to have a stable control of the number of active cases, while the intervention
measures can be gradually relaxed. Stable means that sufficiently small fluctuations of the
number of infected are damped and do not lead to a new exponential outbreak of the
epidemic. Indeed, substituting u(t) = (1 + ε)N(t)/(R0S(t)) into the model equations (1a)–
(1g) yields a linear, autonomous dynamical system (up to the state-dependent mortality
rate (4a)–(4b)), which is easily seen to evolve close to a stable dynamical equilibrium for
ε < 0 and |ε|  1, see Appendix B. The optimal transmission control function is shown
in Fig. 6 along with the analytical approximation (13), the stability criterion (14) and the
corresponding effective reproduction number for the critical period.
We formulate the stability criterion (14) once again in a different way. Since it holds
S(t) ≈ N(0) – Ncases(t), where Ncases(t) is the cumulative number of cases that includes
next to the active cases also the recovered and deceased population Ncases(t) = Nact(t) +
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Hence, since the optimal control depends solely on the cumulative number of cases, it is
crucial to have an accurate estimate of Ncases at any time during the critical period. Next,
we derive an upper limit for the admissible rate of change of u(t). By differentiating Eq. (14),


























Using the approximation (13), the rate on which the measures can be relaxed is limited by





The numerically computed optimal control obeys the criteria (15)–(16), see Fig. 6, and
is therefore (weakly) stable against small perturbations. The merely weak stability reflects
the demand for minimal socio-economic costs, see Sect. 3. The two rules (15)–(16) for the
optimal and stable steering of the transmission control function are widely independent
of the details of the current model system. Equivalent results for a stable dynamical equi-
librium with a constant number of infected cases are easily obtained for the much simpler
SIR model.
The characteristic duration Tcrit of the critical period is estimated from Eq. (13) and the
















which is in excellent agreement with the numerically obtained values for the FWHM time
plotted in Fig. 5(d). Finally, we estimate of the total number of disease-related deaths from

















which is independent of C0, cf. Sect. 4.2 and Fig. 5(e).
4.4 Final phase of the intervention
Finally, we briefly discuss the moderate tightening of the measures in the last (third) phase
of the intervention. To this end, we compare the optimal intervention scenario with a
nearly optimal control, which lacks the last intervention phase as shown in Fig. 7. In the
case of nearly optimal control, the mean contact reduction after the initial lockdown con-
tinuously follows the course of the stability boundary (14), which leads to an excess of
infections beyond the required herd immunity threshold, see Fig. 7(a). The final state
therefore is considerably further in the stable region than required. This implies that more
infections than necessary are passed through, which results in exceeding the minimum
number of deaths (not shown), cf. Eq. (18). In order to prevent this, the measures must be
slightly tightened towards the end of the intervention such that the number of active cases
is diminished and thus an unnecessary decrease of the susceptible population below the
herd immunity threshold is avoided.
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Figure 7 (a) Comparison of the optimal (dashed) and near optimal (dotted) control of the mean contact
reduction. In the near optimal control, the strengthening of the measures in the final phase of the
intervention is omitted. Instead, the near optimal control adheres to the stability boundary (14) and causes an
overshoot of the susceptible population below the stability threshold (S(T ) < N(T )/R0), (b) Plot of the
corresponding effective reproduction number
5 Summary and conclusions
Non-pharmaceutical measures to control the spread of infectious diseases and to prevent
a potential collapse of the health care system must be precisely coordinated in terms of
timing and intensity. Based on well-calibrated mathematical models, the optimal interven-
tion strategy for specific scenarios and objectives can be computed using continuous-time
optimal control theory.
In this paper, an extended SEIR model was calibrated to reproduce the data of the ini-
tial exponential growth phase of the COVID-19 pandemic in Germany. Optimal control
theory has been applied for the scenario in which an effective vaccine is impossible or will
never be found and the epidemic must be controlled with purely non-pharmaceutical mea-
sures. We have computed the optimal control of the transmission rate that satisfies com-
peting objectives: First, the minimization of the disease-related deaths by strictly avoiding
an overflow of intensive care resources and, second, the suppression of a second outbreak
by establishing sufficient natural immunity at the end of the measures. Moreover, the to-
tal costs of the intervention shall be kept at a necessary minimum for socio-economic
reasons.
The optimal control obtained in this paper is a single-intervention scenario that exhibits
several notable features, which allow to structure the whole intervention into three dis-
tinct phases: (i) strict initial lockdown, (ii) critical period and (iii) moderate tightening
of measures in the final phase. The obtained control differs from the results described in
related works [43, 44, 47], but is comparable to the NPI strategy presented in Ref. [48].
We have shown that our optimized time-resolved NPI policy is robust under parameter
variation and developed a qualitative understanding of its distinct phases.
The comparison of the computed optimal transmission control function with the stabil-
ity criteria (15)–(16) reveals, however, that the obtained solution is in fact a tightrope walk
close to the stability boundary of the system, where socio-economic costs and the risk of a
new outbreak must be constantly balanced against one another. Furthermore, our analysis
clearly shows that the goal of achieving herd immunity via natural infections is either ex-
tremely expensive (in terms of socio-economic costs due to measures maintained over a
long period of time) or extremely dangerous (due to the constantly high load on intensive
care resources just below the stability limit). Note that the values of C0 considered in the
computations are relatively high throughout. In any case, in view of the long duration and
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the enormous number of infections that this route entails, as well as the uncertain role of
sequelae and the uncertain prospects for appropriate vaccines, it is strongly advisable to
consider other strategies, in particular the attempt to reduce the number of cases to a level
that is manageable for case tracking [62] or to eradicate the epidemic completely [63].
Appendix A: Stability analysis of the disease-free stationary state
Without intervention, i.e. u = 1, the system (1a)–(1g) has a family of disease-free stationary
states x̄ = (S̄, 0, 0, 0, 0, R̄, D̄). The stability of a stationary state with respect to small pertur-
bations x̄ → x̄ + δx(t) is determined by the sign of the real parts of the eigenvalues η of the









0 0 –βS̄/N̄ 0 0 0 0
0 –γl βS̄/N̄ 0 0 0 0
0 γl –γi 0 0 0 0
0 0 (1 – m)γi –γh (1 – f0)γc 0 0
0 0 0 cγh –γc 0 0
0 0 mγi (1 – c)γh 0 0 0









with N̄ = S̄ + R̄. From the characteristic polynomial












–(γi + γl) ±
√









–(γc + γh) ±
√
(γc – γh)2 + 4c(1 – f0)γcγh
)
,
and the threefold degenerate eigenvalue η(0) = 0. Since c(1 – f0) < 1, it holds η(2)± < 0. The
leading eigenvalue is η(1)+ , which is negative for
S̄/N̄ < R–10 , (19)
see Fig. 8. Hence, the disease-free stationary state is unstable if the susceptible population
size exceeds a critical threshold value that is given by the inverse basic reproduction num-
ber (5). For S̄/N̄ < R–10 an epidemic outbreak is suppressed by a sufficiently high degree of
herd immunity.
Appendix B: Dynamical equilibrium and stability during the critical period
For the stability analysis of the dynamical equilibrium during the critical period it is suf-





, Ė = βu(t)
IS
N
– γlE, İ = γlE – γiI,
Kantner and Koprucki Journal of Mathematics in Industry           (2020) 10:23 Page 17 of 23
Figure 8 The stability of the disease-free stationary state
depends on the size of the susceptible population S̄ and the
basic reproduction numberR0. For S̄/N <R–10 , the outbreak of
an epidemic is suppressed by a sufficiently high degree of herd
immunity
is a nonlinear and non-autonomous dynamical system. Substituting the control function






yields a linear and autonomous system
Ṡ = –(1 + ε)γiI, Ė = (1 + ε)γiI – γlE, İ = γlE – γiI.
For ε = 0, it is easily seen that Ė + İ = 0, such that there exists a dynamical equilibrium
with a constant number of actively infected: E∗ + I∗ = const., where E∗ = (1 + γi/γl)I∗. The
corresponding susceptible population is linearly decreasing on a rate γS = γiI∗. The sta-
bility of the dynamical equilibrium (E∗, I∗) is determined by the roots of the characteristic
polynomial
0 = Λ2 + (γl + γi)Λ – γlγiε










Clearly, for ε > 0, the dynamical equilibrium becomes unstable due to Λ+ > 0. The stability
boundary is given by ε = 0, on which the dynamical equilibrium exists. The optimal control
obtained in the main text drives the system slightly below the stability boundary (ε < 0,
|ε|  1), see Fig. 6(a). In this case it holds Λ± < 0, such that the system is weakly stable
against small perturbations, because the number of active cases is constantly decreasing.
Appendix C: Parameter adjustment
The parameters are adjusted such that the model reproduces the data of the early expo-
nential growth phase of the COVID-19 pandemic in Germany. It is of course questionable
to calibrate an epidemic model to a single country, but in a scenario with extensive bor-
der closures this seems to be justified. In the exponential growth phase of the epidemic,
all sub-populations grow exponentially with the same rate, see Fig. 2(b). This observation
can be exploited to derive a series of algebraic equations (which hold approximately in the
initial phase of the epidemic) that relate all state variables to each other. On the basis of
Kantner and Koprucki Journal of Mathematics in Industry           (2020) 10:23 Page 18 of 23
empirical data (reported number of cases and deaths etc.), several missing model parame-
ters can be directly determined from the algebraic relations. The number of reported cases
and deaths used in this study is based on the figures provided by the Robert Koch-Institute
[64, 65].
One starts with the ansatz
I(t) ≈ I(0)eΓ t , S(t) ≈ N(0), (20)
where Γ is the initial exponential growth rate that is estimated from reported data (see
Fig. 2(b)) as Γ ≈ 0.26d–1 (doubling time of infections within Γ –1 log (2) ≈ 2.67d). Substi-















Note that Eq. (21) is equivalent to the equation for the leading eigenvalue η(1)+ if the whole
population is susceptible, i.e. Γ = η(1)+ |S̄=N(0) (see Appendix A). Hence, Eq. (21) implies that
the exponential growth rate Γ changes sign atR0 = 1, i.e., the epidemic recedes forR0 < 1.
The mean incubation period was reported to be 5.1d, but there are indications that the
latency time may be shorter [66]. Assuming the onset of infectiousness 2.5d before the
onset of symptoms, this implies an average latency period of γ –1l = 2.6d, i.e., the latency
period is assumed to equal roughly half of the incubation period. The reported values of
the basic reproduction number R0 are heavily scattered. According to the Robert Koch
Institute, serious estimates range between 2.4 and 3.3 [67]. In the following R0 = 2.7 shall
be used, which is situated approximately in the middle of the interval in question. From
Eq. (21), the corresponding average infectious period is obtained as γ –1i ≈ 2.35d.
The overall infection fatality rate of COVID-19 was estimated as 0.66% [68], such that
(1 – m)cf0 = 0.0066. On April 8, the Robert Koch Institute reported that a fraction of f0 =
0.31 patients in a critical state died (without ICU overflow) [69]. Finally, the fraction of
infected with at most mild symptoms is estimated as m = 0.92, such that c = 0.0213/(1 –
m) ≈ 0.266.
Substituting the exponential ansatz (20) in Eqs. (1d)–(1g), yields
































with K = 1 + (γh +γc)/Γ +γcγh(1 – (1 – f0)c)/Γ 2. The analytically obtained ratio between all
sub-population and deaths (which are believed to be the most reliably reported data) are
plotted along with the corresponding numerically exact result for the initial uncontrolled
epidemic in Fig. 9(b). The analytical results imply the relation
D(t)/C(t) = γcf0/Γ . (22)
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Figure 9 Ratio of the state variables in the initial
exponential growth phase and the number of disease
related deaths. The numerically exact solution (solid
lines) is plotted along with an analytical approximation
(solid lines) that holds in the early stage of the epidemic.
The corresponding algebraic relations are used to
describe ratios between different sub-populations to
facilitate the parameter adjustment. Symbols indicate the
reported number of disease-related deaths (black),
estimated number of cases (grey) and estimated ICU load
(purple) of the COVID-19 pandemic in Germany. See the
text for details. During mid-March, strict social distancing
measures were implemented, that flattened the initial
exponential growth
Unfortunately, there is only little data available on the demand for ICUs in the early
phase of the epidemic. In mid-March 2020, i.e. near the end of the initial exponential
growth phase, the German Interdisciplinary Association for Intensive Care and Emer-
gency Medicine (DIVI) initiated a register that reports on the availability of ICUs in Ger-
many [70]. On March 27, 687 out of 1160 hospitals with ICUs contributed to the register
and reported a total number of 939 COVID-19 patients in a critical state receiving in-
tensive care [71]. At the same day, 253 disease-related deaths were reported. From the
estimated ratio C/D ≈ 6.3 (the actual number of critical patients was estimated based on
the ratio of contributing and non-contributing hospitals as C ≈ 1586), the average period
after which patients in a critical state either recover or die, is estimated from Eq. (22) as
γ –1c ≈ 7.5d.
Finally, assuming that only r = 2/3 of all cases have been discovered initially and an as-
sumed average time delay between infection and report of cases of tr = 5d, the number
of actual cases is estimated from the number of reported cases as Nestcases(t) = r–1N
rep
cases(t +
tr) = r–1eΓ tr N
rep
cases(t) ≈ 5.5N repcases(t). This yields a good agreement between the simu-
lated number of cases (Ncases = E + I + H + C + R + D) and Nestcases before measures came
into force, see Fig. 2(a) and Fig. 9. The average time between infection and death td
can be estimated from the ratio Nestcases(t)/D(t) ≈ 2370 (see Fig. 8(b)) and Nestcases(t – td) =
Nestcases(t)e–Γ td = D(t) as td ≈ 29.9d.
Appendix D: Two-point boundary value problem
Rescaling the populations x = (S, E, I, H , C, R, D) subject to the dynamical system (1a)–(1g)
by the initial population size N(0) and using N(t) = N(0) – D(t), see Eq. (3), we obtain the
equations of motion for the rescaled sub-populations x̃(t) = x(t)/N(0) as
˙̃S = –βu(t) Ĩ S̃
1 – D̃
, (23a)
˙̃E = βu(t) Ĩ S̃
1 – D̃
– γlẼ, (23b)
˙̃I = γlẼ – γiĨ, (23c)
˙̃H = (1 – m)γiĨ +
(
1 – f (C̃/C̃0)
)
γcC̃ – γhH̃ , (23d)
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˙̃C = cγhH̃ – γcC̃, (23e)
˙̃R = mγiĨ + (1 – c)γhH̃ , (23f)
˙̃D = f (C̃/C̃0)γcC̃, (23g)
where C̃0 = C0/N(0). The co-state equations of the optimal control problem considered in
Sect. 3 for the rescaled Lagrange multipliers λ̃(t) = N(0)λ(t) read
˙̃





λE(t) = L + γl(λ̃E – λ̃I),
˙̃









λH (t) = L + γh
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The initial conditions are taken as
S̃(0) = 1 – Ẽ(0), Ẽ(0) = 2.41 × 10–7, Ĩ(0) = H̃(0) = C̃(0) = R̃(0) = D̃(0) = 0,






































λ̃D(T) = N(0)P .
The choice of the initial time conditions guarantees u(0) = 1 (no intervention) at the be-
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